Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1559 |  LEGN Legend Biotech Corporation - American Depositary Shares | 18.71 USD | -2.14% | -3.16% | -7.47% | -41.49% | 3.46 B USD | ||
| 1573 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 19.58 USD | -0.36% | -2.20% | -29.13% | -6.58% | 3.37 B USD | ||
| 1584 |  CELC Celcuity Inc. - Common Stock | 67.87 USD | +3.18% | -9.66% | -23.20% | +38.12% | 3.32 B USD | ||
| 1598 |  VKTX Viking Therapeutics, Inc. - Common Stock | 27.73 USD | -2.84% | -10.11% | -14.68% | -22.54% | 3.23 B USD | ||
| 1617 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 72.22 USD | -1.89% | -4.77% | -16.32% | +9.32% | 3.17 B USD | ||
| 1640 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.49 USD | +1.32% | -3.96% | +3.68% | +18.14% | 3.08 B USD | ||
| 1646 |  DYN Dyne Therapeutics, Inc. - Common Stock | 16.37 USD | +2.50% | +2.12% | -15.53% | -30.07% | 3.06 B USD | ||
| 1658 |  RCUS Arcus Biosciences, Inc. Common Stock | 23.82 USD | -2.89% | -6.33% | -15.14% | +56.92% | 3.03 B USD | ||
| 1660 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.20 USD | -0.84% | -4.56% | -14.63% | +88.63% | 3.03 B USD | ||
| 1670 |  DNLI Denali Therapeutics Inc. - Common Stock | 18.67 USD | -2.56% | -10.46% | -13.92% | +15.46% | 2.98 B USD | ||
| 1673 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 40.63 USD | -1.76% | -14.25% | -31.19% | +96.66% | 2.98 B USD | ||
| 1720 |  ZLAB Zai Lab Limited - American Depositary Shares | 24.81 USD | -1.98% | +0.69% | -2.13% | -7.04% | 2.79 B USD | ||
| 1738 |  PGEN Precigen, Inc. - Common Stock | 7.60 USD | +0.80% | -8.43% | +13.43% | +136.76% | 2.72 B USD | ||
| 1787 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 21.26 USD | -3.93% | -13.58% | -16.13% | -41.38% | 2.54 B USD | ||
| 1788 |  BEAM Beam Therapeutics Inc. - Common Stock | 24.60 USD | -0.69% | -1.60% | -0.73% | -13.62% | 2.54 B USD | ||
| 1797 |  LQDA Liquidia Corporation - Common Stock | 28.02 USD | +5.02% | +4.98% | -58.42% | +23.98% | 2.51 B USD | ||
| 1839 |  IRON Disc Medicine, Inc. - Common Stock | 60.77 USD | -0.67% | -5.87% | -19.92% | -13.81% | 2.33 B USD | ||
| 1843 |  ADMA ADMA Biologics Inc - Common Stock | 10.33 USD | +1.87% | +3.09% | +10.01% | -30.11% | 2.31 B USD | ||
| 1851 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 39.60 USD | +0.66% | -0.45% | -5.74% | +28.16% | 2.31 B USD | ||
| 1852 |  NRIX Nurix Therapeutics, Inc. - Common stock | 22.21 USD | -2.29% | -6.37% | -16.00% | +98.13% | 2.30 B USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |